CARDS on the table: should everybody with type 2 diabetes take a statin?

Author： Lee J.D.   Morrissey J.R.   Mikhailidis D.P.   Patel V.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.3, 2005-03, pp. : 357-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time to initiation of oral antihyperglycemic and statin therapy in previously untreated patients with type 2 diabetes in the United States

By Sun Peter  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 801-806

Informa Healthcare

Access to resources Recommend Favorite

Screening for type 2 diabetes

By Macrae Malcolm J  

British Journal of General Practice, Vol. 54, Iss. 507, 2004-10 ,pp. : 785-785

Royal College of General Practitioners

Access to resources Recommend Favorite

Contents

By  

DIABETIC MEDICINE, Vol. 32, Iss. S1, 2015-03 ,pp. : 17-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

C‐peptide: should we be testing this routinely in the Type 1 diabetes clinic?

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : 1259-1260

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome studies in type 2 diabetes

By Hanefeld M.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 41-52

Informa Healthcare

Access to resources Recommend Favorite